{"id":"W4206576793","doi":"10.1200/jco.2021.39.15_suppl.4080","title":"Lenvatinib plus pembrolizumab for patients with previously treated biliary tract cancers in the multicohort phase 2 LEAP-005 study.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Lenvatinib; Medicine; Pembrolizumab; Internal medicine; Response Evaluation Criteria in Solid Tumors; Oncology; Clinical endpoint; Adverse effect; Phases of clinical research; Cohort; Gastroenterology; Surgery; Cancer; Sorafenib; Toxicity; Clinical trial; Immunotherapy; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001685615,0.0001808293,0.001536803,0.00008720708,0.00006564763,0.00001255513,0.0001652614,0.0001605228,0.00003674648],"category_scores_gemma":[0.002365705,0.00009716602,0.0003844722,0.0002351189,0.0001446203,0.0000958941,0.00002989112,0.0007785989,0.000001349815],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004047118,"about_ca_system_score_gemma":0.002861462,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001065895,"about_ca_topic_score_gemma":0.001074928,"domain_scores_codex":[0.9968076,0.0004702647,0.001739079,0.000267689,0.0004253694,0.00029001],"domain_scores_gemma":[0.9955639,0.002521919,0.0008818572,0.000253494,0.0006096404,0.0001691455],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01751619,0.01080468,0.9034987,0.00004077272,0.000715805,0.001288152,0.002036964,0.00001800301,0.000006423199,0.000002271153,0.0028178,0.06125425],"study_design_scores_gemma":[0.08009761,0.03960077,0.8656606,0.00009702358,0.001056257,0.0001477565,0.002055893,0.00004955342,0.00001106307,0.000008263323,0.0111161,0.00009910624],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933295,0.001130919,0.00001474222,0.003271013,0.0004551152,0.00115515,0.00001006296,0.000006301208,0.0006272038],"genre_scores_gemma":[0.9965157,0.0003268698,0.0003978697,0.001927965,0.0006387351,0.00005935038,0.00001156787,0.00001971697,0.0001022077],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06258142,"threshold_uncertainty_score":0.5076112,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1192102743183958,"score_gpt":0.4667918343486225,"score_spread":0.3475815600302268,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}